BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 24485765)

  • 1. Second primary cancers after radiation for prostate cancer: a systematic review of the clinical data and impact of treatment technique.
    Murray L; Henry A; Hoskin P; Siebert FA; Venselaar J;
    Radiother Oncol; 2014 Feb; 110(2):213-28. PubMed ID: 24485765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second primary cancers occurring after I-125 brachytherapy as monotherapy for early prostate cancer.
    Musunuru H; Mason M; Murray L; Al-Qaisieh B; Bownes P; Smith J; Franks K; Carey B; Bottomley D; Henry AM
    Clin Oncol (R Coll Radiol); 2014 Apr; 26(4):210-5. PubMed ID: 24507938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of subsequent primary cancers and radiation-induced subsequent primary cancers after low dose-rate brachytherapy monotherapy for prostate cancer in long-term follow-up.
    Vuolukka K; Auvinen P; Palmgren JE; Aaltomaa S; Kataja V
    BMC Cancer; 2020 May; 20(1):453. PubMed ID: 32434560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second primary cancers after radiation for prostate cancer: a review of data from planning studies.
    Murray L; Henry A; Hoskin P; Siebert FA; Venselaar J;
    Radiat Oncol; 2013 Jul; 8():172. PubMed ID: 23835163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of second malignancies after
    Fernandez Ots A; Browne L; Chin YS; Malouf D; Wong K; Bucci J
    Brachytherapy; 2016; 15(6):752-759. PubMed ID: 27475483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in radiotherapy and its impact on second primary cancer risk: A multi-center cohort study in prostate cancer patients.
    Jahreiß MC; Hoogeman M; Aben KK; Dirkx M; Snieders R; Pos FJ; Janssen T; Dekker A; Vanneste B; Minken A; Hoekstra C; Smeenk RJ; Incrocci L; Heemsbergen WD
    Radiother Oncol; 2023 Jun; 183():109659. PubMed ID: 37003369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of second primary cancer following prostate cancer radiotherapy: DVH analysis using the competitive risk model.
    Takam R; Bezak E; Yeoh EE
    Phys Med Biol; 2009 Feb; 54(3):611-25. PubMed ID: 19124952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Risk of Second Primary Cancers in Prostate Cancer Survivors Treated in the Modern Radiotherapy Era.
    Jahreiß MC; Aben KKH; Hoogeman MS; Dirkx MLP; de Vries KC; Incrocci L; Heemsbergen WD
    Front Oncol; 2020; 10():605119. PubMed ID: 33282746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of second cancers according to radiation therapy technique and modality in prostate cancer survivors.
    Berrington de Gonzalez A; Wong J; Kleinerman R; Kim C; Morton L; Bekelman JE
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):295-302. PubMed ID: 25636756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second Primary Cancer in Patients with Differentiated Thyroid Cancer: Does Radioiodine Play a Role?
    Silva-Vieira M; Carrilho Vaz S; Esteves S; Ferreira TC; Limbert E; Salgado L; Leite V
    Thyroid; 2017 Aug; 27(8):1068-1076. PubMed ID: 28614983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
    Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer.
    Murray L; Mason J; Henry AM; Hoskin P; Siebert FA; Venselaar J; Bownes P;
    Radiother Oncol; 2016 Aug; 120(2):293-9. PubMed ID: 27370205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of second cancer following radiotherapy for prostate cancer: a population-based analysis.
    Hegemann NS; Schlesinger-Raab A; Ganswindt U; Hörl C; Combs SE; Hölzel D; Gschwend JE; Stief C; Belka C; Engel J
    Radiat Oncol; 2017 Jan; 12(1):2. PubMed ID: 28049538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Seed Migration Increase the Risk of Second Malignancies in Prostate Cancer Patients Treated With Iodine-125 Loose Seeds Brachytherapy?
    Vigneault E; Martell K; Taussky D; Husain S; Delouya G; Mbodji K; Piotte J; Magnan S; Després P; Lavallée MC; Aubin S; Beaulieu L; Foster W; Martin AG
    Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1190-1194. PubMed ID: 29428250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study on the risk of second primary cancers in out-of-field organs associated with radiotherapy of localized prostate carcinoma using Monte Carlo-based accelerator and patient models.
    Bednarz B; Athar B; Xu XG
    Med Phys; 2010 May; 37(5):1987-94. PubMed ID: 20527532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources. A report of ICRP Publication 98.
    International Commission on Radiological Protection
    Ann ICRP; 2005; 35(3):iii-vi, 3-50. PubMed ID: 16330284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy.
    Murray LJ; Thompson CM; Lilley J; Cosgrove V; Franks K; Sebag-Montefiore D; Henry AM
    Phys Med Biol; 2015 Feb; 60(3):1237-57. PubMed ID: 25590229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic overview of radiation therapy effects in prostate cancer.
    Nilsson S; Norlén BJ; Widmark A
    Acta Oncol; 2004; 43(4):316-81. PubMed ID: 15303499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate brachytherapy and second primary cancer risk: a competitive risk analysis.
    Hinnen KA; Schaapveld M; van Vulpen M; Battermann JJ; van der Poel H; van Oort IM; van Roermund JG; Monninkhof EM
    J Clin Oncol; 2011 Dec; 29(34):4510-5. PubMed ID: 22025166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing Risk for Second Primary Cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for Prostate Cancer, 2002-2015.
    Pithadia KJ; Advani PG; Citrin DE; Bekelman JE; Withrow DR; Berrington de Gonzalez A; Morton LM; Schonfeld SJ
    JAMA Oncol; 2023 Aug; 9(8):1119-1123. PubMed ID: 37289449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.